Researchers have established that these genes can also be involved in the development of non-hereditary, sporadic tumours, as a proportion of ovarian and breast cancers contain somatic (tumour only) BRCA1 and BRCA2 pathogenic variants [5-15]. The gene discussed is BRCA2; the disease is breast carcinoma.